tiprankstipranks
pc:rapaf

Rapafusyn Pharmaceuticals

Therapeutics
Rapafusyn Pharmaceuticals is a pioneering company in the discovery and development of non-degrading molecular glue therapeutics. Utilizing its proprietary RapaGlue™ platform, Rapafusyn focuses on creating innovative macrocyclic molecules to target challenging and previously undruggable disease targets. The company leverages advanced machine learning and AI methods for target selection and drug candidate optimization, addressing high unmet medical needs in oncology, immunology, renal, and pain diseases. Rapafusyn's approach enhances drug discovery by forming neo-protein-protein interactions, offering promising therapeutic potential.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$44M
Total Amount Raised$44M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$44M
Latest Funding Amount$44M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 04, 2025
Series A
$44.00M
―

Investors

Investor Name
Funding Round
BioTrack Capital
Series A
Lapam Capital
Series A
3E Bioventures Capital
Series A
Yonjin Capital
Series A
Proxima Ventures
Series A

Similar Companies

A snapshot of private companies similar to Rapafusyn Pharmaceuticals, helping you discover and navigate related company profiles.
PC:GAMETGameto
PC:CYTEDCyted Health
PC:PRENEPrenetics Global Limited
PC:WELLSWELLSTAR Technologies Corp

Related News and Analysis

Rapafusyn Pharmaceuticals Targets Investors With H.C. Wainwright Conference Spotlight

Rapafusyn Pharmaceuticals Targets Investors With H.C. Wainwright Conference Spotlight

New updates have been reported about Rapafusyn Pharmaceuticals. Rapafusyn Pharmaceuticals will seek to deepen its investor engagement this...
13d ago
RAPAF
Giggles Relaunches With Aura Points System and Overhauled Video Platform

Giggles Relaunches With Aura Points System and Overhauled Video Platform

New updates have been reported about Giggles. Giggles has completed a full relaunch of its social video app,...
44m ago
GIGGL
Faye Launches Intercom–NetSuite Integration to Surface Financial Data in Real Time

Faye Launches Intercom–NetSuite Integration to Surface Financial Data in Real Time

New updates have been reported about Faye. Faye has introduced a new integration between Intercom and Oracle NetSuite...
1h ago
FAYEX
Thatch Hits $1 Billion Valuation on 7x Revenue Surge as Employers Shift Health Benefits Model

Thatch Hits $1 Billion Valuation on 7x Revenue Surge as Employers Shift Health Benefits Model

New updates have been reported about Thatch. Thatch has raised $108 million in new funding at a $1...
2h ago
THATC
Forward Financing Secures $1.8 Billion Capital Pact After Passing 100,000 SMB Customers

Forward Financing Secures $1.8 Billion Capital Pact After Passing 100,000 SMB Customers

New updates have been reported about Forward Financing. Forward Financing has marked a major scale milestone, surpassing 100,000...
2h ago
FORWA
Saol Therapeutics Secures Up to $115 Million from Oaktree to Fund SL1009 Launch and Pipeline Expansion

Saol Therapeutics Secures Up to $115 Million from Oaktree to Fund SL1009 Launch and Pipeline Expansion

New updates have been reported about Saol Therapeutics. Saol Therapeutics has entered into a definitive financing agreement with...
3h ago
SAOLT
Decimal AI Raises $4 Million to Scale Customer Engineering Platform for Software Support

Decimal AI Raises $4 Million to Scale Customer Engineering Platform for Software Support

New updates have been reported about Decimal AI. Decimal AI has secured $4 million in seed funding to...
3h ago
DEC1O
Sorcero Elevates Medical Affairs With Unified AI Platform and Strategy Analytics

Sorcero Elevates Medical Affairs With Unified AI Platform and Strategy Analytics

New updates have been reported about Sorcero. Sorcero is significantly expanding its Sorcero Medical™ platform with a Fall...
3h ago
SORCE
Visier’s Org Design Platform Named 2026 Top HR Product, Underscoring Strategic Role in Workforce Planning

Visier’s Org Design Platform Named 2026 Top HR Product, Underscoring Strategic Role in Workforce Planning

New updates have been reported about Visier. Visier has strengthened its position in AI-powered workforce management with its...
4h ago
VISIE
Ractigen Therapeutics Unveils First-in-Human RNA Activation Data in Duchenne Muscular Dystrophy

Ractigen Therapeutics Unveils First-in-Human RNA Activation Data in Duchenne Muscular Dystrophy

New updates have been reported about Ractigen Therapeutics. Ractigen Therapeutics will present first-in-human data from its RAG-18 Duchenne...
5h ago
RACTI